Diabetes mellitus is associated with well-known increases in cardiovascular morbidity and mortality. In diabetics with stable coronary artery disease, the best therapeutic option is widely discussed. Current studies comparing surgical to percutaneous revascularization have been unable to definitely demonstrate any significant advantage of one strategy over the other regarding the prevention of cardiac death or acute myocardial infarction. Therefore, even taking into account clinical and angiographic information as well as the risks determined by each type of treatment, the decision regarding the best therapeutic strategy in diabetics with stable coronary artery disease is still complex.
Keywords: Coronary artery bypass graft surgery, coronary artery disese, diabetes mellitus, Revascularization, FOR, CORONARY ARTERY DISEASE, plasminogen, diabetic nephropathy, pharmacologic stents, proximal lesions, Theoretically, FREEDOM
Rights & PermissionsPrintExport